Table 2.
Phytocompound | Source | In Vivo Method/Model | Biological Activity | Reference |
---|---|---|---|---|
1. EXCISION/INCISION WOUNDS MODEL | ||||
Betulin | Birch bark | Pig ear/porcine ex vivo excision wound healing model and re-epithelialization | Formation of the skin barrier, wound healing, re-epithelization | [5] |
Lupeol | Bowdichia virgilioides | Male Wistar rats/streptozotocin induced hyperglycemia- excision wound model |
Enhancement of the healing process through the anti-inflammatory effect of NF-κb signaling pathways | [24] |
Asiaticoside | Centella asiatica | Rabbits/excision wound | Shortening of the epithelization period by increase in hydroxyproline content and induction of collagen synthesis | [25] |
Pure compound |
Rabbits/excision wound | Accelerated wound healing, keloid prevention formation, invisible scar formation in open wounds showing tissue loss | [26] | |
Pure compound |
Guinea pigs/excision wound | Enhanced rate of wound healing by increase in collagen synthesis and tensile strength of the wound tissues |
[27] | |
Oleanolic acid | Anredera diffusa | Male mice/excision wound | Enhanced cicatrizant activity | [28] |
Bacosides | Bacopa monnieri | Swiss Wistar strain rats/incision wound models | Acceleration of epithelialization and wound contraction rate | [29] |
Astragaloside IV, Cyclocephaloside I Cyclocanthoside E | Pure compounds |
Sprague–Dawley male rats/incision wound model | Wound healing by enhanced cell density, regularly organized dermis and angiogenesis | [23] |
Astragaloside IV | Pure compound |
Sprague-Dawley (SD) female rats/excision model | Faster wound closure by increased collagen synthesis and TGF-β1 levels | [30] |
Pure compound |
Sprague–Dawle female rat/skin excision wound model | Acceleration of the wound re-epthelization, angiogenesis, scar prevention | [31] | |
2. BURN/THERMAL WOUNDS MODEL | ||||
Asiaticoside | Centella asiatica | Male Balb/c mice/burn wound model | Increase in burn wound repair by VEGF and IL-1β production |
[32] |
Pure compound |
Sprague-Dawley rats/burn wound model | Accelerated skin recovery in deep partial-thickness burn injury by VEGF prodiuction | [33] | |
Madecassoside | Centella asiatica | Male ICR mice/burn wound model | Accelerated burn wound healing by increased antioxidative activity, collagen synthesis and angiogenesis. |
[34] |
Pure compound |
Male Sprague-Dawley rats/burn wound model | Accelerated burn wound healing, wound contraction by stimulation of collagen synthesis, reducing oxidative stress and inducing vasodilatation | [35] | |
Pure compound |
SD rats/burn wound model | Scar reduction and wound healing improvement | [36] | |
Glycyrrhizin | Pure compound |
BALB/c mice/burn wound model | Restores the synthesis of β-defensins and enhances the resistance to infection with Pseudomonas aeruginosa | [37] |
Pure compound |
Male Sprague-Dawley rats/thermal injury model | Anti-inflammatory effect and organ protection by inhibition of HMGB1 | [38] | |
Ginsenosides | Panax ginseng CA Meyer | Male Balb/c mice/burn wound model | Reduction of wound area, enhanced wound healing by increased neovascularization and VEGF production | [39] |
Bacosides | Pure compound |
New Zealand Albino rabbits/thermal injury model | Reduction of the scarring area and scarring thickness by downregulation of MMP-1 or TGF-β1 proteins | [40] |
3. SKIN FLAP WOUNDS MODEL | ||||
Betulinic acid | Pure compound |
Male C57BL/6 mice/random-pattern skin flap model | Promotion of angiogenesis, reduction of tissue edema, increase in the survivability of the skin flap | [41] |
Asiaticoside | Pure compound |
Male Sprague–Dawley rats/experimental model of rat skin flaps | Enhancement in microcirculation and viability of the skin flaps | [42] |
4. DIABETIC WOUNDS MODEL | ||||
Asiaticoside | Pure compound |
SPF SD male rats/diabetic wound model | Accelerated healing of diabetic cutaneous ulcers by regulating Wnt/β-Catenin signaling pathway | [43] |
Pure compound |
Sprague Dawley male rats/diabetic wound model |
Enhanced rate of wound healing by increase in collagen synthesis and tensile strength of the wound tissues |
[27] | |
5. GASTRIC ULCER MODEL | ||||
Oleanolic acid | Fabiana imbricata | Male Swiss Albino mice/induced gastric ulcer model | Gastroprotective effect | [44] |
Fabiana imbricata | Male Sprague–Dawley rats/induced gastric ulcer model | Regeneration of the lesions, increase in gastric mucosal thickness | [45] | |
6. INFECTED WOUND MODEL | ||||
Cycloastragenol
(cycloastragenol-6-O-beta-D-glucoside) |
Astragalus membranaceus | Male C57BL/6JNarl mice/infected wound healing | Wound healing activity by stimulation of angiogenesis | [21] |
Astragaloside VI | Astragalus membranaceus | Male C57BL/6JNarl mice/infected wounds | Promotion of cutaneous wound healing by enhanced angiogenesis | [21] |
7. PSORIASIS MODEL | ||||
Betulinic acid | Dillenia indica | Ultraviolet induced psoriasis-like wounds/male albino Wistar rats | Accelerated healing process | [2] |
8. EDEMA MODEL | ||||
Asiatic acid | Pure compound |
ICR mice/hind paw edema model |
Anti-inflammatory activities, pain relief by inhibition of iNOS, COX-2, interleukin-6, IL-1β, and TNF-α expression | [46] |
9. AORTIC CONTRACTION/RELAXATION MODEL | ||||
Betulinic acid | Pure compound |
Male Sprague Dawley rats exposed to LPS/aortic contraction-realaxation in sepsis | Reduction in impairments of aortic contraction; antiinflamatory effect | [47] |